nasoshield
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 3, 2018 (NCT03352466)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Bacillus anthracisImmunity, active
Bacillus anthracis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04415749 | Phase 1 | Jun 30, 2020 | Altimmune, Inc., Department of Health and Human Services |
| NCT03352466 | Phase 1 | Feb 3, 2018 | Altimmune, Inc., ICON |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Altimmune, Inc. | For profit | 2 | 2 | 1 | 2018 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2020 |
| ICON | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1